Intestinal Polyposis: Clinical Trials

3 trials for Intestinal Polyposis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Unknown 3
Phase 21Unknown 1

Follow Intestinal Polyposis: new trials by email Literature Review of Intestinal Polyposis trials Research Report on Intestinal Polyposis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis
celecoxib monotherapy, celecoxib and metformin combination - Familial Adenomatous Polyposis
Phase 3UnknownYonsei University282024-08-132024-08-09
Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis
Eicosapentaenoic acid free fatty acid (EPA-FFA), Placebo - Familial Adenomatous Polyposis
Phase 3UnknownS.L.A. Pharma AG2042018-12-052024-04-25
Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients
Ursodeoxycholic acid, Placebo - Adenomatous Polyposis Coli, Familial
Phase 2 / Phase 3UnknownAssistance Publique - Hôpitaux de Paris902004-10-012009-07-29

Narrower conditions

Adenomatous Polyposis Coli (3)  ·  Adenoma (1)  ·  Polyps (1)

Broader conditions

Adenomatous Polyps (3)  ·  Colonic Diseases (3)  ·  Colorectal Neoplasms (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Digestive System Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Gastrointestinal Diseases (3)  ·  Gastrointestinal Neoplasms (3)  ·  Genetic Diseases, Inborn (3)  ·  Intestinal Diseases (3)  ·  Intestinal Neoplasms (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)

Interventions

Celecoxib (1)  ·  Docosahexaenoic Acids (1)  ·  Ursodeoxycholic Acid (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  S.L.A. Pharma AG (1)  ·  Yonsei University (1)

Countries

France (1)  ·  Italy (1)  ·  South Korea (1)

Top investigators

Luigi Ricciardiello, MD (1)  ·  Yann RA Parc, M.D., Ph.D. (1)

Results publications

PMID 21899713